Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01063075
Title A Study in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
University of Kansas Medical Center Fairway Kansas 66205 United States Details
Portland VA Medical Center Portland Oregon 91239 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London Ontario N6A 4L6 Canada Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal Quebec H3G 1A4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field